SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, will bring its SSi Mantra surgical robotic system to one of the largest annual gatherings of robotic surgery specialists, highlighting the company's expanding clinical experience and growing focus on remote surgical capabilities. The company announced that the SSi Mantra will be showcased during the Society of Robotic Surgery (“SRS”) 2026 Annual Meeting, scheduled for July 23-26 in Hollywood, Florida (https://ibn.fm/FkgsY).
The robotic platform will be demonstrated throughout the conference and featured in multiple technical sessions. One of the event's focal points will be a live robotic telesurgery in which a partial nephrectomy will be performed remotely from India, demonstrating the remote capabilities of the SSi Mantra platform. Chairman and CEO Dr. Sudhir Srivastava will participate in multiple conference presentations covering telesurgery, robotic surgery adoption and regulatory developments.
As of July 6, 2026, more than 12,375 procedures have been completed using the SSi Mantra system, including cardiac, pediatric and telesurgical procedures. Approximately 2,100 physicians have already been trained on the platform, which has been used across more than 170 different surgical procedures. This extensive clinical experience underscores the system's versatility and growing acceptance in the surgical community.
The SRS 2026 conference provides a platform for SS Innovations to showcase its technology to a global audience of robotic surgery specialists. The live telesurgery broadcast is particularly significant as it demonstrates the potential for remote surgical interventions, which could expand access to specialized surgical care in underserved regions. The company's focus on telesurgery aligns with broader trends in healthcare toward telemedicine and remote care delivery.
For investors and industry observers, the presentation at SRS 2026 highlights SS Innovations' progress in commercializing its surgical robotic system. The company's ability to demonstrate live telesurgery on an international stage could bolster confidence in its technology and open new markets. The latest news and updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII.
Forward-looking statements in this article are subject to risks and uncertainties, including those described in the company's SEC filings. All parties undertake no duty to update this information unless required by law.
